Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 16, 2022International Journal of CancerOpen Access

Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab

View Full Paper
Ask AI
Bookmark
Share

Authors

GMGiulia MartiniUniversity of Campania "Luigi Vanvitelli"DCDavide CiardielloEuropean Institute of OncologyMDMarcello DallioUniversity of Campania "Luigi Vanvitelli"

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Martini et al. (2022) studied this question.

synapsesocial.com/papers/6a213ed3c52df660f64def4fhttps://doi.org/10.1002/ijc.34033
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Microbiota, Disease, and Back to Health: A Metastable Journey2012 · 285 citations
  2. 2Comparative Analysis of Pyrosequencing and a Phylogenetic Microarray for Exploring Microbial Community Structures in the Human Distal Intestine2009 · 895 citations
  3. 3Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion2021 · 280 citations
  4. 4Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies2012 · 9,290 citations
  5. 5Nivolumab in Previously Untreated Melanoma without BRAF Mutation2014 · 5,462 citations